These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1357 related articles for article (PubMed ID: 20932597)

  • 1. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
    Jiang TT; Luo XP; Sun JM; Gao J
    World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
    Ganger DR; Klapman JB; McDonald V; Matalon TA; Kaur S; Rosenblate H; Kane R; Saker M; Jensen DM
    Am J Gastroenterol; 1999 Mar; 94(3):603-8. PubMed ID: 10086638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
    D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI
    Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation.
    Wils A; van der Linden E; van Hoek B; Pattynama PM
    J Clin Gastroenterol; 2009; 43(10):982-4. PubMed ID: 19417681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients.
    Qi X; Han G; Yin Z; He C; Wang J; Guo W; Niu J; Zhang W; Bai M; Fan D
    Dig Dis Sci; 2012 Apr; 57(4):1072-82. PubMed ID: 22147244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis.
    Van Ha TG; Hodge J; Funaki B; Lorenz J; Rosenblum J; Straus C; Leef J
    Cardiovasc Intervent Radiol; 2006; 29(5):785-90. PubMed ID: 16850140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma.
    Fanelli F; Angeloni S; Salvatori FM; Marzano C; Boatta E; Merli M; Rossi P; Attili AF; Ridola L; Cerini F; Riggio O
    Dig Liver Dis; 2011 Jan; 43(1):78-84. PubMed ID: 20637712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis.
    Perarnau JM; Baju A; D'alteroche L; Viguier J; Ayoub J
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1093-8. PubMed ID: 20308910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transjugular intrahepatic portosystemic shunt in patients with portal vein thrombosis].
    Streitparth F; Santosa F; Milz J; Gebauer B; Teichgräber U; Hamm B; Hidajat N
    Rofo; 2008 Oct; 180(10):899-905. PubMed ID: 19238640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein.
    Wang L; He F; Yue Z; Zhao H; Fan Z; Zhao M; Qiu B; Yao J; Lin Q; Dong X; Liu F
    Sci Rep; 2017 Sep; 7(1):10868. PubMed ID: 28883536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular portosystemic shunt in chronic portal vein occlusion: importance of segmental portal hypertension in cavernous transformation of the portal vein.
    Walser EM; Soloway R; Raza SA; Gill A
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):373-8. PubMed ID: 16517786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.